Market Access with Real-World Evidence

Optimizing Market Access with Real-World Evidence via Point-of-Care Derived Insight

When is market access important?

From pre-launch, phase II & III, to approval and throughout a product’s lifecycle, to loss of exclusivity. The application of real-world evidence (RWE) during these critical periods help to optimize market success by providing rapid market access insights when they matter most. The days of being able to focus on safety and efficacy alone have passed. Today each medication choice must ensure appropriate patients have streamlined and maintained access to the care plan medications of choice, at the right cost to the patient.

What are the key components of a successful market access strategy?

Building a robust value story to drive market access by:

  • Gathering access intelligence at the point of care
  • Successfully navigating utilization management tactics by facilitating decision making via real world evidence to benefit the appropriate patients in a timely and cost-effective manner
  • Securing patient response to medication data along with expert analytics to support appropriate medication use and outcome tracking
  • Procuring electronic medical record patient flow data including longitudinal patient level practice patterns

Why Veradigm?

Veradigm uniquely provides insight from the point of patient care, extending throughout everyday life. We translate complex market dynamics into clear actionable strategic managed market considerations, through our analytical expertise, point of care network, and market access experience. We welcome the opportunity to optimize your market access success via our data-driven insights delivered through novel technologies.